Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of California at Davis Health System
mi
from
Sacramento, CA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of California at Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of California at San Francisco
mi
from
San Francisco, CA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Emory Hospital
mi
from
Atlanta, GA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Emory Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of Chicago, Division of Infectious Diseases
mi
from
Chicago, IL
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Indiana BMT
mi
from
Beech Grove, IN
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Indiana BMT
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Infectious Disease of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Henry Ford Hospital
mi
from
Detroit, MI
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Wayne State University School of Medicine
mi
from
Detroit, MI
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Wayne State University School of Medicine
mi
from
Detroit, MI
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Upstate Infectious Diseases Association LLP
mi
from
Albany, NY
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Cleveland Clinic
mi
from
Cleveland, OH
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Regional Infection Diseases Infusion Center Inc.
mi
from
Lima, OH
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Temple University Health Sciences
mi
from
Philadelphia, PA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Temple University Health Sciences
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of Pittsburgh Medical Center Health System
mi
from
Pittsburgh, PA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of Pittsburgh Medical Center Health System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Fred Hutchinson Cancer Research Center, Clinical Research
mi
from
Seattle, WA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Fred Hutchinson Cancer Research Center, Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Stanford University Hospital
mi
from
Stanford, CA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Stanford University Hospital
mi
from
Stanford, CA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
UMASS Memorial Medical Center
mi
from
Worcester, MA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
Hospital Italiano de Buenos Aires
mi
from
Ciudad Autonoma,
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
Hospital Italiano de Buenos Aires
mi
from
Ciudad Autonoma,
Click here to add this to my saved trials
Multinight CPAP for Sleep Apnea Patients
Evaluation of a Multinight (MNT) CPAP Titration Algorithm in Patients With Sleep Apnea.
Status: Enrolling
Updated:  12/7/2017
New York University School of Medicine
mi
from
New York, NY
Multinight CPAP for Sleep Apnea Patients
Evaluation of a Multinight (MNT) CPAP Titration Algorithm in Patients With Sleep Apnea.
Status: Enrolling
Updated: 12/7/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/7/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
Randomized Open-Label Crossover Trial Comparing Tolerability of a Cardioselective Beta-Blocker (Metoprolol-Succinate-ER) and a Non-Cardioselective Beta-Blocker (Carvedilol) in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/7/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Birmingham, AL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
LA BioMed at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
LA BioMed at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of California at San Francisco
mi
from
San Francisco, CA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
National Jewish Health
mi
from
Denver, CO
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Illinois Health System
mi
from
Chicago, IL
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Illinois Health System
mi
from
Chicago, IL
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
LSU Health
mi
from
New Orleans, LA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
LSU Health
mi
from
New Orleans, LA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Boston, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Reliant Medical Group
mi
from
Worcester, MA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Reliant Medical Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Ann Arbor, MI
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Veteran's Administration Medical Center
mi
from
Minneapolis, MN
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Veteran's Administration Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
HealthPartners Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Lovelace Respiratory Research Institute
mi
from
Albuquerque, NM
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Lovelace Respiratory Research Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Western New York Veterans Administration Healthcare System
mi
from
Buffalo, NY
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Western New York Veterans Administration Healthcare System
mi
from
Buffalo, NY
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Duke University
mi
from
Durham, NC
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Cincinnati VAMC
mi
from
Cincinnati, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Cincinnati VAMC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Cleveland Clinic
mi
from
Cleveland, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Ohio State University
mi
from
Columbus, OH
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Oregon Health and Science University
mi
from
Portland, OR
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated:  12/8/2017
Geisinger Medical Center
mi
from
Danville, PA
Simvastatin Therapy for Moderate and Severe COPD
Prospective Randomized Placebo-Controlled Trial of SimvaSTATin in the Prevention of COPD Exacerbations (STATCOPE)
Status: Enrolling
Updated: 12/8/2017
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials